3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors

Molecular Simulation

Volumn 39, Issue 5, 2013, Pages 385-396

  Singh, Udghosh ^a   Gangwal, Rahul P ^a   Prajapati, Rameshwar ^a   Dhoke, Gaurao V ^a   Sangamwar, Abhay T ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

3D QSAR; matrix metalloproteinase 12; molecular docking; pharmacophore; virtual screening

Indexed keywords

3D-QSAR; MATRIX METALLOPROTEINASE-12; MOLECULAR DOCKING; PHARMACOPHORES; VIRTUAL SCREENING;

AMINO ACIDS; CHEMICAL COMPOUNDS; COMPLEXATION; COMPUTATIONAL CHEMISTRY; HYDROGEN BONDS; HYDROPHOBICITY; MOLECULAR MODELING; SCAFFOLDS; THREE DIMENSIONAL COMPUTER GRAPHICS;

PHARMACODYNAMICS;

EID: 84873413022     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2012.731506     Document Type: Article

References (36)

1. S.E. Gill and W.C. Parks, Metalloproteinases and their inhibitors: Regulators of wound healing, Int. J. Biochem. Cell Biol. 40 (2008), pp. 1334-1347.
2. H. Nagase, R. Visse, and G. Murphy, Structure and function of matrix metalloproteinases and TIMPs, Cardiovasc. Res. 69 (2006), pp. 562-573.
3. S.D. Shapiro, D.K. Kobayashi, and T.J. Ley, Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages, J. Biol. Chem. 268 (1993), pp. 23824-23829.
4. R.D. Hautamaki, D.K. Kobayashi, R.M. Senior, and S.D. Shapiro, Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice, Science 277 (1997), pp. 2002-2004.
5. P.R.A. Pauwels and K.F. Rabe, Burden and clinical features of chronic obstructive pulmonary disease (COPD), Lancet 364 (2004), pp. 613-620.
6. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, S. Menjoge, and M. Decramer, A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N. Engl. J. Med. 359 (2008), pp. 1543-1554.
7. M.G. Belvisi, D.J. Hele, and M.A. Birrell, New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease, Expert Opin. Ther. Targets 8 (2004), pp. 265-285.
8. C. Bergeron and L.P. Boulet, Structural changes in airway diseases Chest 129 (2006), pp. 1068-1087.
9. C. Le Quément, I. Guénon, J.Y. Gillon, S. Valenca, V. Cayron-Elizondo, V. Lagente, and E. Boichot, The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke, Br. J. Pharmacol. 154 (2008), pp. 1206-1215.
10. M.A. Markus, B. Dwyer, S. Wolfrom, J. Li, W. Li, K. Malakian, J. Wilhelm, and D.H.H. Tsao, Solution structure of wild-type human matrix metalloproteinase 12 (MMP-12) in complex with a tightbinding inhibitor, J. Biomol. NMR 41 (2008), pp. 55-60.
11. R. Bhaskaran, M.O. Palmier, N.A. Bagegni, X. Liang, and S.R. Van Doren, Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment, J. Mol. Biol. 374 (2007), pp. 1333-1344.
12. R. Morales, S. Perrier, J.M. Florent, J. Beltra, S. Dufour, I. De Mendez, P. Manceau, A. Tertre, F. Moreau, and D. Compere, Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12, J. Mol. Biol. 341 (2004), pp. 1063-1076.
13. V. Dive, D. Georgiadis, M. Matziari, A. Makaritis, F. Beau, P. Cuniasse, and A. Yiotakis, Phosphinic peptides as zinc metalloproteinase inhibitors, Cell. Mol. Life Sci. 61 (2004), pp. 2010-2019.
14. A.C. Dublanchet, P. Ducrot, C. Andrianjara, M. O'Gara, R. Morales, D. Compère, A. Denis, S. Blais, P. Cluzeau, K. Courté, J. Hamon, F. Moreau, M.-L. Prunet, and A. Tertre, Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors, Bioorg. Med. Chem. Lett. 15 (2005), pp. 3787-3790.
15. E. Nuti, L. Panelli, F. Casalini, S.I. Avramova, E. Orlandini, S. Santamaria, S. Nencetti, T. Tuccinardi, A. Martinelli, and G. Cercignani, Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors, J. Med. Chem. 52 (2009), pp. 6347-6361.
16. W. Li, J. Li, Y. Wu, F. Rancati, S. Vallese, L. Raveglia, J. Wu, R. Hotchandani, N. Fuller, and K. Cunningham, Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma, J. Med. Chem. 52 (2009), pp. 5408-5419.
17. I.P. Holmes, S. Gaines, S.P. Watson, O. Lorthioir, A. Walker, S.J. Baddeley, S. Herbert, D. Egan, M.A. Convery, and O.M.P. Singh, The identification of b-hydroxy carboxylic acids as selective MMP-12 inhibitors, Bioorg. Med. Chem. Lett. 19 (2009), pp. 5760-5763.
18. W. Li, J. Li, Y. Wu, J. Wu, R. Hotchandani, K. Cunningham, I. McFadyen, J. Bard, P. Morgan, and F. Schlerman, A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): Discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3- sulfonamido)-3-methylbutanoic acid (MMP408), J. Med. Chem. 52 (2009), pp. 1799-1802.
19. Y. Wu, J. Li, J. Wu, P. Morgan, X. Xu, F. Rancati, S. Vallese, L. Raveglia, R. Hotchandani, and N. Fuller, Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD), Bioorg. Med. Chem. Lett. 22 (2011), pp. 138-143.
20. Discovery Studio Version 2.5 (DS 2.5) User Manual, Accelrys, Inc., San Diego, CA, 2009.
21. A. Smellie, S.L. Teig, and P. Towbin, Poling: Promoting conformational variation, J. Comput. Chem. 16 (1995), pp. 171-187.
22. Y. Kurogi and O.F. Guner, Pharmacophore modeling and threedimensional database searching for drug design using catalyst, Curr. Med. Chem. 8 (2001), pp. 1035-1055.
23. J. Wang, M. Yan, D. Zhao, Y. Sha, F. Li, and M. Cheng, Pharmacophore identification of PAK4 inhibitors, Mol. Simul. 36 (2010), pp. 53-57.
24. R. Singh, A. Balupuri, and M.E. Sobhia, Development of 3D-pharmacophore model followed by successive virtual screening, molecular docking and ADME studies for the design of potent CCR2 antagonists for inflammation-driven diseases, Mol. Simul. (2012) doi: 10.1080/08927022.08922012.08701743.
25. N. Bharatham, K. Bharatham, and K.W. Lee, Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors, J. Mol. Graph. Model. 25 (2007), pp. 813-823.
26. G.V. Dhoke, R.P. Gangwal, and A.T. Sangamwar, A combined ligand and structure based approach to design potent PPAR-alpha agonists, J. Mol. Struct. 1028 (2012), pp. 22-30.
27. S. Gupta, A. Fallarero, P. Järvinen, D. Karlsson, M.S. Johnson, P.M. Vuorela, and C.G. Mohan, Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques, Bioorg. Med. Chem. Lett. 21 (2011), pp. 1105-1112.
28. S. Gupta and C. Gopi Mohan, 3D-pharmacophore model based virtual screening to identify dual-binding site and selective acetylcholinesterase inhibitors, Med. Chem. Res. 20 (2011), p. 1422.
29. E.P. Semighini, C.A. Taft, and C.H.T.P. Silva, Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design, Mol. Simul. 37 (2011), pp. 1186-1206.
30. R. Brenk, A. Schipani, D. James, A. Krasowski, I.H. Gilbert, J. Frearson, and P.G. Wyatt, Lessons learnt from assembling screening libraries for drug discovery for neglected diseases, ChemMedChem 3 (2008), pp. 435-444.
31. G.R. Bickerton, G.V. Paolini, J. Besnard, S. Muresan, and A.L. Hopkins, Quantifying the chemical beauty of drugs, Nat. Chem. 4 (2012), pp. 90-98.
32. Glide Version 5.5, Schrodinger, LLC, New York, 2009.
33. P.S. Ambure, R.P. Gangwal, and A.T. Sangamwar, 3D-QSAR and molecular docking analysis of biphenyl amide derivatives as p38a mitogen-activated protein kinase inhibitors, Mol. Divers. 16 (2012), pp. 377-388.
34. B.W. Dymock, X. Barril, P.A. Brough, J.E. Cansfield, A. Massey, E. McDonald, R.E. Hubbard, A. Surgenor, S.D. Roughley, and P. Webb, Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design, J. Med. Chem. 48 (2005), pp. 4212-4215.
35. Y. Wang, E. Bolton, S. Dracheva, K. Karapetyan, B.A. Shoemaker, T.O. Suzek, J. Wang, J. Xiao, J. Zhang, and S.H. Bryant, An overview of the PubChem BioAssay resource, Nucleic Acids Res. 38 (2010), pp. D255-D266.
36. A.B. Wagner, SciFinder Scholar 2006: An empirical analysis of research topic query processing, J. Chem. Inf. Model. 46 (2006), pp. 767-774.